Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg

Journal of Medical Screening

Volumn 24, Issue 1, 2017, Pages 34-42

  Nyström, Lennarth ^a   Bjurstam, Nils ^b   Jonsson, Håkan ^a   Zackrisson, Sophia ^c,d   Frisell, Jan ^e  

^a UMEÅ UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast cancer mortality; Mammography; Randomized controlled trial; Screening; Sweden

Indexed keywords

ADULT; AGED; BREAST TUMOR; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MORTALITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; REMINDER SYSTEM; STATISTICS AND NUMERICAL DATA; SWEDEN; THEORETICAL MODEL;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MODELS, THEORETICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; REMINDER SYSTEMS; SWEDEN;

EID: 85016209129     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141316648987     Document Type: Article

References (19)

1. Nyström L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised studies. Lancet 1993; 341: 973–978.
2. Larsson L-G, Andersson I, Bjurstam N, et al. Updated overview of the Swedish randomised trials on breast cancer screening with mammography: age group 40–49 at randomisation. JNCI Mono 1997; 22: 57–61.
3. Nystroöm L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish trials. Lancet 2002; 359: 909–919.
4. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmoö Mammographic Screening Trial. BMJ 1988; 297: 943–948.
5. Andersson I and Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmoö Mammographic Screening Program. JNCI Mono 1997; 22: 63–67.
6. Frisell J, Glas U, Hellströ m L, et al. Randomised mammographic screening for breast cancer in Stockholm. Design, first round results and comparison. Breast Cancer Res Treat 1986; 8: 45–54.
7. Frisell J, Eklund G, Hellström L, et al. Randomised study of mammography screening in the Stockholm trial. Breast Cancer Res Treat 1991; 18: 49–56.
8. Bjurstam N, Bjöneld L, Duffy SW, et al. The Gothenburg breast screening trial. First results on mortality, incidence, and mode of detection for women ages 39–49 years at randomisation. Cancer 1997; 80: 091–099.
9. Bjurstam N, Bjoörneld L, Duffy SW, et al. The Gothenburg breast cancer screening trial: preliminary results on breast cancer mortality for women aged 39–49. JNCI Mono 1997; 22: 53–55.
10. Nyström L, Larsson L-G, Rutqvist LE, et al. Determination of cause of death among breast cancer cases in the Swedish randomised mammography screening trials. A comparison between official statistics and validation by an endpoint committee. Acta Oncol 1995; 34: 145–152.
11. Larsson L-G, Nystro¨m L, Wall S, et al. The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality. J Med Screen 1996; 3: 129–132.
12. Taba´r L, Vitak B, Hsiu-His T, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011; 260: 658–663.
13. Shapiro S, Venet W, Strax P, et al. Ten- to fourteen-year effect of screening on breast cancer mortality. JNCI 1982; 69: 349–355.
14. Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999; 353: 1903–1908.
15. Miller AB, To T, Baines CJ, et al. The Canadian National Breast Screening Study – 1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Int Med 2002; 137: 305–312.
16. Miller AB, To T, Baines CJ, et al. The Canadian National Breast Screening Study – 2: 13-year results of a randomized trial in women aged 50–59 years. JNCI 2000; 92: 1490–1499.
17. Miller AB, Wall C, Baines CJ, et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomized screening trial. BMJ 2014; 348: g366.
18. Holmberg L, Duffy SW, Yen AMF, et al. Differences in endpoints between the Swedish W-E (two-County) trial of mammography screening and the Swedish overview: methodological consequences. J Med Screen 2009; 16: 73–80.
19. Duffy SW and Smith RA. A note on the design of cancer screening trials. J Med Screen 2015; 22: 65–68.